PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
20-Jul-2020 Sanifit to start new clinical development program of SNF472 in End Stage Kidney Disease patients with Peripheral Artery Disease Sanifit
20-Jul-2020 PTC Therapeutics Announces Agreement to Monetize a Portion of the Risdiplam Royalty Stream for $650 Million PTC Therapeutics, Inc.
17-Jul-2020 Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription Verona Pharma plc
17-Jul-2020 MARINOMED BIOTECH AG: CARRAGELOSE® EFFECTIVE AGAINST SARS-CoV-2 IN CELL CULTURE ASSAYS Marinomed Biotech AG
17-Jul-2020 Farxiga granted Fast Track Designation in the US for heart failure following acute myocardial infarction leveraging an innovative registry-based trial design AstraZeneca
17-Jul-2020 PureTech Founded Entity Vor Biopharma Appoints Daniella Beckman to its Board of Directors PureTech Health plc
17-Jul-2020 RedHill Biopharma Receives Approval for Phase 2/3 COVID-19 Study in Russia RedHill Biopharma Ltd
17-Jul-2020 Genmab Announces Net Sales of DARZALEX® for the Second Quarter of 2020 Genmab
17-Jul-2020 Celltrion launches human clinical trial of potential COVID-19 antiviral antibody treatment following positive pre-clinical results Celltrion Healthcare
17-Jul-2020 ASLAN PHARMACEUTICALS ANNOUNCES THE MOVE OF ITS PRIMARY LISTING TO NASDAQ AND DELISTING FROM TAIPEI EXCHANGE ASLAN Pharmaceuticals
17-Jul-2020 SurePulse lands £1m investment to expand its share of neonatal healthtech market SurePulse Medical Ltd
17-Jul-2020 Thermo Fisher Scientific NGS Assay to be Leveraged for Lung Cancer Testing in Israel Thermo Fisher Scientific
17-Jul-2020 Eli Lilly’s and Regeneron’s COVID-19 mAbs spark interest as monotherapies along with potential as cocktails for treatment and postexposure prevention, says GlobalData GlobalData
17-Jul-2020 Idorsia establishes US commercial operations and leadership team Idorsia Ltd
17-Jul-2020 Tiziana Announces Submission of Patent Application on Use of Foralumab, the Only Fully Human Anti-CD3 Monoclonal Antibody, to Enhance Success of CAR-T Therapy Tiziana Life Sciences plc
17-Jul-2020 Sosei Heptares Successfully Raises US$200 million in International Offering of New Shares and Convertible Bonds Sosei Group Corporation
17-Jul-2020 Tiziana Announces Submission of Patent Application on Use of Foralumab, the Only Fully Human Anti-CD3 Monoclonal Antibody, to Enhance Success of CAR-T Therapy Tiziana Life Sciences plc
17-Jul-2020 Idorsia establishes US commercial operations and leadership team Idorsia Ltd
17-Jul-2020 Tiziana Life Sciences plc Change to ADS Ratio - Updated Tiziana Life Sciences plc
15-Jul-2020 Atos establishes Life Sciences Centre of Excellence to support researchers worldwide Atos